Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

PUBLICATION DATE

9 results
Display

Obesity and PPARdelta

Hwang H, Kim S, Kang H

  • KMID: 1515267
  • J Korean Soc Endocrinol.
  • 2004 Jun;19(3):250-255.
No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Current Understanding of Peroxisome Proliferator-Activated Receptor delta

Ham J, Won DH, Kang H

  • KMID: 2200302
  • J Korean Soc Endocrinol.
  • 2003 Jun;18(3):239-249.
No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
An Activation of Peroxisome Proliferator-Activated Receptor delta Attenuate Alcoholic Liver Disease and Nonalcoholic Fatty Liver Disease in Rats

Kim SM, Yoon DK, Yang BS, Cho KH

  • KMID: 2078202
  • Korean J Obes.
  • 2005 Mar;14(1):29-38.
BACKGROUND: Author used the rat model of alcoholic and nonalcoholic liver disease in which feeding dietary with ethanol and high fat result in the development of fatty liver, necrosis, and...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effects of Peroxisome Proliferator-Activated Receptor (PPAR) Delta on the Growth and Invasion of a Thyroid Cancer Cell Line

Kim WG, Choi HJ, Kim EY, Kim TY, Kim WB, Kim SC, Shong YK

BACKGROUND: Peroxisome proliferator-activated receptor delta (PPAR-delta) is a ligand-activated nuclear transcription factor that is associated with many diseases, such as diabetes, obesity, metabolic syndrome, and cancer. However, the function of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Peroxisome Proliferator-Activated Receptor delta Agonist, GW501516, Inhibits Angiogenesis through Dephosphorylation of Endothelial Nitric Oxide Synthase

Kim JB, Lee SH, Ahn J, Kim J

OBJECTIVE: Peroxisome proliferator-activated receptor delta (PPAR-delta) is an ubiquitously expressed nuclear receptor that has been implicated in adipose tissue formation, brain development, and atherosclerosis. Despite mouse studies demonstrating that PPAR-delta...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Peroxisome proliferator-activated receptor delta agonist attenuates hepatic steatosis by anti-inflammatory mechanism

Lee MY, Choi R, Kim HM, Cho EJ, Kim BH, Choi YS, Naowaboot , Lee EY, Yang YC, Shin JY, Shin YG, Chung CH

  • KMID: 1506221
  • Exp Mol Med.
  • 2012 Oct;44(10):578-585.
Although peroxisome proliferator receptor (PPAR)-alpha and PPAR-gamma agonist have been developed as chemical tools to uncover biological roles for the PPARs such as lipid and carbohydrate metabolism, PPAR-delta has not...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Fenofibrate, a peroxisome proliferator-activated receptor alpha-agonist, blocks lipopolysaccharide-induced inflammatory pathways in mouse liver

Won TW

BACKGROUNDS/AIMS: During the acute phase response, cytokines induce marked alterations in lipid metabolism including an increase in serum triglyceride levels and a decrease in hepatic fatty acid oxidation, in bile...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Anti-cancer Effects of a Novel Quinoline Derivative 83b1 on Human Esophageal Squamous Cell Carcinoma through Down-Regulation of COX-2 mRNA and PGEâ‚‚

Pun IH, Chan D, Chan SH, Chung PY, Zhou YY, Law S, Lam AK, Chui CH, Chan AS, Lam KH, Tang JC

PURPOSE: 83b1 is a novel quinoline derivative that has been shown to inhibit cancer growth in human esophageal squamous cell carcinoma (ESCC). This study was conducted to comprehensively evaluate the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effects of Different Types of Dietary Fat on Muscle Atrophy According to Muscle Fiber Types and PPARdelta Expression in Hindlimb-Immobilized Rats

Lee HU, Park MN, Lee YS

This study investigated how dietary fat affects muscle atrophy and lipid metabolism in various muscles during hindlimb immobilization in rats. Twenty-four male Sprague-Dawley rats had their left hindlimb immobilized and...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr